The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(4-Methoxybenzylidene)-3-(4-chlorophenyl)-3,4-dihydro-2H-thiazolo[3,2-a][1,3,5]triazin-6(7H)-one ID: ALA4555125
PubChem CID: 1311270
Max Phase: Preclinical
Molecular Formula: C19H16ClN3O2S
Molecular Weight: 385.88
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(/C=c2/sc3n(c2=O)CN(c2ccc(Cl)cc2)CN=3)cc1
Standard InChI: InChI=1S/C19H16ClN3O2S/c1-25-16-8-2-13(3-9-16)10-17-18(24)23-12-22(11-21-19(23)26-17)15-6-4-14(20)5-7-15/h2-10H,11-12H2,1H3/b17-10+
Standard InChI Key: CEPZIRGVYPRXDU-LICLKQGHSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
16.7004 -24.9013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4502 -24.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1090 -23.6424 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.7719 -24.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5119 -24.9041 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0539 -25.5157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8589 -25.3535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1190 -24.5740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5741 -23.9566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3995 -25.9615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1382 -26.7370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6786 -27.3489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4805 -27.1867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7390 -26.4070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1969 -25.7983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6729 -23.8724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0659 -24.4195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2894 -24.1648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6827 -24.7111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8527 -25.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6348 -25.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2382 -25.2143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2897 -25.6125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0225 -27.7982 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.2464 -26.0592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4687 -25.8081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
4 5 1 0
1 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
4 9 2 0
7 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
2 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
1 23 2 0
13 24 1 0
20 25 1 0
25 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.88Molecular Weight (Monoisotopic): 385.0652AlogP: 2.46#Rotatable Bonds: 3Polar Surface Area: 46.83Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.14CX LogP: 4.99CX LogD: 4.99Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: -1.52
References 1. Hassan GS, Georgey HH, Mohammed EZ, Omar FA.. (2019) Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors., 184 [PMID:31604164 ] [10.1016/j.ejmech.2019.111747 ]